Professional
Added to YB: 2026-01-08
Pitch date: 2026-01-07
CLPT [neutral]
ClearPoint Neuro, Inc.
-41.36%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
Market Cap
$272.3M
Pitch Price
$15.28
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.10
P/E
-10.18
EV/Sales
7.70
Sector
Health Care Equipment and Supplies
Category
N/A
Pernas Research Passes On: ClearPoint Neuro, Inc.
CLPT (pass): MRI-guided neurosurgery tools w/ modest growth (HSD-low teens YoY). Slow adoption due to switching costs & retraining needs. Mgmt pivoting to gene therapy delivery platform but commercialization much further out than implied. Core imaging biz proven but growth insufficient to justify expansion assumptions.
Read full article (1 min)